These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 37996289)
1. Excess mortality in Cyprus during the COVID-19 vaccination campaign. Economidou EC; Soteriades ES Vaccine; 2024 May; 42(15):3375-3376. PubMed ID: 37996289 [No Abstract] [Full Text] [Related]
2. Authors' reply: Excess mortality in Cyprus during the COVID-19 vaccination campaign. Lytras T; Athanasiadou M; Demetriou A; Stylianou D; Heraclides A; Kalakouta O Vaccine; 2024 May; 42(15):3377-3378. PubMed ID: 38670843 [No Abstract] [Full Text] [Related]
3. Effect of Pfizer/BioNTech and Oxford/AstraZeneca vaccines against COVID-19 morbidity and mortality in real-world settings at countrywide vaccination campaign in Saudi Arabia. Meo SA; Fahad Al-Jassir F; Al-Qahtani S; Albarrak R; Usmani AM; Klonoff DC Eur Rev Med Pharmacol Sci; 2021 Nov; 25(22):7185-7191. PubMed ID: 34859883 [TBL] [Abstract][Full Text] [Related]
4. Lack of association between vaccination rates and excess mortality in Cyprus during the COVID-19 pandemic. Lytras T; Athanasiadou M; Demetriou A; Stylianou D; Heraclides A; Kalakouta O Vaccine; 2023 May; 41(18):2941-2946. PubMed ID: 37012116 [TBL] [Abstract][Full Text] [Related]
5. The world's largest COVID-19 vaccination campaign. Bagcchi S Lancet Infect Dis; 2021 Mar; 21(3):323. PubMed ID: 33639124 [No Abstract] [Full Text] [Related]
6. Direct impact of COVID-19 vaccination in Chile: averted cases, hospitalizations, ICU admissions, and deaths. Brault A; Hart A; Uribe P; Prado J; San Martín J; Maass A; Canals M BMC Infect Dis; 2024 May; 24(1):467. PubMed ID: 38698324 [TBL] [Abstract][Full Text] [Related]
7. COVID-19 Australia: Epidemiology Report 38 Reporting period ending 28 March 2021. COVID-19 National Incident Room Surveillance Team Commun Dis Intell (2018); 2021 Apr; 45():. PubMed ID: 33845717 [No Abstract] [Full Text] [Related]
8. Evaluation of a COVID-19 Vaccine Campaign and SARS-CoV-2 Infection and Mortality Among Adults Aged 60 Years And Older in a Middle-Income Country. Macchia A; Ferrante D; Angeleri P; Biscayart C; Mariani J; Esteban S; Tablado MR; de Quirós FGB JAMA Netw Open; 2021 Oct; 4(10):e2130800. PubMed ID: 34714342 [TBL] [Abstract][Full Text] [Related]
9. How COVID vaccines shaped 2021 in eight powerful charts. Mallapaty S; Callaway E; Kozlov M; Ledford H; Pickrell J; Van Noorden R Nature; 2021 Dec; 600(7890):580-583. PubMed ID: 34916666 [No Abstract] [Full Text] [Related]
10. In favour of a bespoke COVID-19 vaccines compensation scheme. Fairgrieve D; Holm S; Howells G; Kirchhelle C; Vanderslott S Lancet Infect Dis; 2021 Apr; 21(4):448-450. PubMed ID: 33548195 [No Abstract] [Full Text] [Related]
11. Impact of SARS-CoV-2 vaccines on Covid-19 incidence and mortality in the United States. Fang F; Clemens JD; Zhang ZF; Brewer TF PLoS One; 2024; 19(4):e0301830. PubMed ID: 38656933 [TBL] [Abstract][Full Text] [Related]
12. Using syndromic measures of mortality to capture the dynamics of COVID-19 in Java, Indonesia, in the context of vaccination rollout. Djaafara BA; Whittaker C; Watson OJ; Verity R; Brazeau NF; Widyastuti ; Oktavia D; Adrian V; Salama N; Bhatia S; Nouvellet P; Sherrard-Smith E; Churcher TS; Surendra H; Lina RN; Ekawati LL; Lestari KD; Andrianto A; Thwaites G; Baird JK; Ghani AC; Elyazar IRF; Walker PGT BMC Med; 2021 Jun; 19(1):146. PubMed ID: 34144715 [TBL] [Abstract][Full Text] [Related]
13. Protective Behaviors Against COVID-19 by Individual Vaccination Status in 12 Countries During the Pandemic. Goldszmidt R; Petherick A; Andrade EB; Hale T; Furst R; Phillips T; Jones S JAMA Netw Open; 2021 Oct; 4(10):e2131137. PubMed ID: 34698850 [TBL] [Abstract][Full Text] [Related]
17. Covid-19 vaccine management (Comirnaty and mrna-1273 Moderna) in a teaching hospital in Italy: a short report on the vaccination campaign. Papini F; Grassi N; Guglielmi G; Gattini V; Rago L; Bisordi C; Scateni M; Totaro M; Tulipani A; Porretta A; Tavoschi L; Guercini J; Luchini G; Briani S; Privitera GP; Baggiani A Environ Health Prev Med; 2021 Sep; 26(1):99. PubMed ID: 34592930 [TBL] [Abstract][Full Text] [Related]
18. Infections, hospitalisations, and deaths averted via a nationwide vaccination campaign using the Pfizer-BioNTech BNT162b2 mRNA COVID-19 vaccine in Israel: a retrospective surveillance study. Haas EJ; McLaughlin JM; Khan F; Angulo FJ; Anis E; Lipsitch M; Singer SR; Mircus G; Brooks N; Smaja M; Pan K; Southern J; Swerdlow DL; Jodar L; Levy Y; Alroy-Preis S Lancet Infect Dis; 2022 Mar; 22(3):357-366. PubMed ID: 34562375 [TBL] [Abstract][Full Text] [Related]
19. SARS-CoV-2 Infections and Hospitalizations Among Persons Aged ≥16 Years, by Vaccination Status - Los Angeles County, California, May 1-July 25, 2021. Griffin JB; Haddix M; Danza P; Fisher R; Koo TH; Traub E; Gounder P; Jarashow C; Balter S MMWR Morb Mortal Wkly Rep; 2021 Aug; 70(34):1170-1176. PubMed ID: 34437525 [TBL] [Abstract][Full Text] [Related]
20. Effectiveness of the Pfizer-BioNTech and Oxford-AstraZeneca vaccines on covid-19 related symptoms, hospital admissions, and mortality in older adults in England: test negative case-control study. Lopez Bernal J; Andrews N; Gower C; Robertson C; Stowe J; Tessier E; Simmons R; Cottrell S; Roberts R; O'Doherty M; Brown K; Cameron C; Stockton D; McMenamin J; Ramsay M BMJ; 2021 May; 373():n1088. PubMed ID: 33985964 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]